Area of research
Oncology · Genetics
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, CAR-T cell therapy research, and Chronic Lymphocytic Leukemia Research.
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis
Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
Checkpoint inhibitor-related renal vasculitis and use of rituximab
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis